ORTHO REAGENT RED BLOOD CELLS 0.8% SURGISCREEN
Report
- Report Number
- 2250051-2017-00007
- Event Type
- Malfunction
- Date Received
- February 10, 2017
- Date of Event
- January 18, 2017
- Report Date
- February 9, 2017
- Manufacturer
- ORTHO CLINICAL DIAGNOSTICS
- Product Code
- KSZ
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
ORTHO PERFORMED RETAIN TESTING, BATCH REVIEW, COMPLAINT REVIEW BY LOT, DONOR HISTORY, AND DONOR COMPLAINT REVIEW. ALL RESULTS WERE SATISFACTORY. SAMPLE WAS NOT RETURNED TO ORTHO FOR FURTHER INVESTIGATION. (B)(4).
EVENT 1 OF 5 CUSTOMER REPORTED A FALSE NEGATIVE FOR ANTI-KELL IN MANUAL GEL METHOD WITH FOLLOWING EVENTS: FALSE NEGATIVE WITH CELL# 3 WITH ONE PATIENT WHEN TESTING WITH OPENED 0.8% SURGISCREEN LOT# VSS874 WITH MTS IGG GEL CARD LOT#101016001-01 FALSE NEGATIVE CELL# 11 WITH 3 PATIENTS WHEN TESTING WITH 0.8% RESOLVE PANEL A LOT# VRA266 EXP: 1-31-17 WITH MTS IGG GEL CARDS LOT# 101016001-01 (SEE MXP 1873578) FALSE NEGATIVE CELL# 22 WITH ONE PATIENT WHEN TESTING WITH 0.8 RESOLVE PANEL B LOT#VRB227 WITH MTS IGG GEL CARDS LOT# 101016001-01 (SEE MXP 1873607). PATIENT DID REACT WITH PANEL CELL #17 WITH 1+ REACTIVITY. ORTHO CARE ASKED CUSTOMER WHAT INITIATED CUSTOMER TO PERFORM ANTIBODY IDENTIFICATION PANELS IF ANTIBODY SCREEN WAS NEGATIVE FOR CELL #3, AND CUSTOMER STATED THE TWO PATIENTS HAD PREVIOUS HISTORY OF ANTI-KELL. CUSTOMER RAN THE PANELS BECAUSE IT IS PART OF THEIR PROTOCOL TO RUN A PANEL ON PATIENTS WITH PREVIOUS HISTORY OF AN ANTIBODY. ISSUE STARTED ON: (B)(6) 2017 REPORTED (B)(6) 2017. FREQUENCY: ONE PATIENT. MICROTUBES/WELLS OR CELL (DONOR #) AFFECTED: CELL 3. METHODOLOGY USED: MANUAL GEL METHOD. INCUBATION TIME (FOR MANUAL TEST ONLY): 15 MIN. PATTERN OBSERVED: FALSE NEG. REACTION GRADE OBTAINED: NEG. CUSTOMER WAS EXPECTING: POS. TEST REPEATED: YES. RESULT OBTAINED BY REPEATING:NEG. METHOD USED TO REPEAT: MANUAL GEL METHOD. CUSTOMER REPORTS STORING RED CELL REAGENTS AND MTS GEL CARDS ACCORDING TO IFU. CUSTOMER REPORTS NO SIGNS OF HEMOLYSIS OR HAZE NOTED IN RED CELL REAGENTS. QC DATA: QC TYPE: ALBA Q-CHEK. LAST QC RUN: (B)(6) 2017. CARDS /CASSETTES/ STORAGE CONDITION TEMPERATURE: AS PER IFU VISUAL APPEARANCE BEFORE USE: ACCEPTABLE REAGENT RED BLOOD CELL STORAGE AND HANDLING: AS PER IFU PROTOCOL DETAILS (FOR CUSTOMER WORKING IN MANUAL METHODS): PIPETTE USED: TIPMASTER PIPETTOR MAINTENANCE UP TO DATE. ORTHO CARE ASKED THE CUSTOMER TO TEST WITH AN ALTERNATE LOT OF IGG GEL CARDS, BUT CUSTOMER DID NOT HAVE AN ALTERNATE LOT. ORTHO CARE ASKED CUSTOMER IF RED CELL REAGENTS WERE ALLOWED TO COME TO ROOM TEMPERATURE, CUSTOMER REPORTS YES. ORTHO CARE ASKED CUSTOMER TO TEST SCREENING CELL #3 WITH AN ANTI-KELL ANTISERA. TESTED SCREENING CELL #3 WITH IMMUCOR ANTI-KELL ANTISERA DILUTED WITH BLOOD BANK SALINE WITH REACTIVITY AT 3+ WITH A 1:16 DILUTION IN TUBE METHOD. ORTHO CARE DISCUSSED WITH THE CUSTOMER THAT THE ISSUE IS SAMPLE RELATED, BUT CUSTOMER IS NOT SATISFIED WITH THIS LOT OF SCREENING CELLS. REPLACEMENT IS REQUESTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 107169 | ORTHO REAGENT RED BLOOD CELLS 0.8% SURGISCREEN | REAGENT RED BLOOD CELLS | KSZ | ORTHO CLINICAL DIAGNOSTICS | VSS874 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |